Correlation of medical dosimetry quality indicators to the local tumor control in patients with prostate cancer treated with iodine-125 interstitial implants
- 3 December 1998
- journal article
- research article
- Published by Wiley in Medical Physics
- Vol. 25 (12), 2293-2307
- https://doi.org/10.1118/1.598440
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Iodine 125 seed implants for prostatic carcinoma: Five- and ten-year follow-upUrology, 1993
- External beam irradiation versus 125 iodine implant in the definitive treatment of prostate carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 1991
- Iodine-125 implants versus external beam therapy for stages A2, B, and C prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1988
- A dose homogeneity index for evaluating 1 9 2 Ir interstitial breast implantsMedical Physics, 1988
- A ten year follow-up of 682 patients treated for prostate cancer with radiation therapy in the United StatesInternational Journal of Radiation Oncology*Biology*Physics, 1987
- Preoperative irradiation, lymphadenectomy, and 125iodine implantation for patients with localized carcinoma of the prostateInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Iodine-125 implants for carcinoma of the prostateInternational Journal of Radiation Oncology*Biology*Physics, 1985
- Intra-operative iodine-125 prostatic implant following bilateral pelvic lymphadenectomyInternational Journal of Radiation Oncology*Biology*Physics, 1984
- Physical dosimetry of 125I seeds of a new design for interstitial implantInternational Journal of Radiation Oncology*Biology*Physics, 1983
- 125I implantation for carcinoma of prostate Further follow-up of first 100 casesUrology, 1982